Small Cap News Movers for 8/17/09

Align Technology, Inc. (NASDAQ: ALGN) today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation (NYSE: DHR), to end all pending litigation between the parties and to begin a new strategic collaboration. As part of the settlement, Align will make a cash payment of approximately $13 million to Ormco and issue approximately 7.6 million shares of Align's Common Stock to Danaher Corporation, Ormco's ultimate parent, that after issuance will be equal to approximately ten percent ownership interest in Align. The stock closed at $13.00, up 28.33%, 6,481,681 traded shares.

Protalix BioTherapeutics, Inc. (NYSE AMEX: PLX) announced today that the U.S. Food and Drug Administration (FDA) has approved the Company’s treatment protocol for prGCD, a proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The treatment protocol allows physicians and other care-providers to treat patients of Gaucher disease with prGCD in the United States and additional countries world-wide. The stock closed at $6.39, up 10.75%, on 1,698,204 traded shares

China-Biotics, Inc. (NASDAQ: CHBT) announced its financial results for the first quarter of its 2010 fiscal year, ended June 30, 2009. During the first quarter of the 2010 fiscal year, net sales increased 35.5% to $15.4 million from $11.4 million a year ago. The increase resulted from an increase in sales volume from new products, most of which were sold in the Company's Shining-branded retail outlets, significant growth in the bulk additive business and sales price increases on bulk additives products. The stock closed at $12.17, up 8.47%, on 161,702 traded shares.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future.